In this episode, we talked with professor, systems thinker, and aging researcher, Alan Cohen. Cohen described how controlled experiments continue to dominate the way biologist learn and think, he suggested “this paradigm of complex systems thinking is what can guide us to understand when those controlled experiments are formative or not. The more complex the system the more a lot of factors might be interacting and the more we have to doubt how generalizable our experimental results will be.” During our conversation, Cohen also shared some of the complex questions he is researching in his lab like, “can we integrate biomarkers (Cholesterol, Albumin, Hemoglobin, Glucose) together to get a good idea of what’s happening with the aging process? And what happens if, instead of looking at them [biomarkers] one at a time, we try to integrate their signal and look at what might be happening in terms of underlying processes?” He explained that people who have “high dis-regulation levels” are at greater risk of health complications and that his research on holistic physiology is uncovering fundamental processes in the biology of aging.
In this episode, Angie talked with Francesco Filia, CEO of Fasanara Capital, an unconventional, boutique asset management company which focuses on niche investment strategies and researches systemic risk. Filia shared his perspective on the way financial markets are conventionally analyzed saying, “analysis that is typically performed on financial markets, in my opinion, is quite outdated. It has not evolved and could learn so much from nearby fields such as complexity theory.” He described financial markets as ecosystems and continued to bring many different insights from complexity into the conversation, including how feedback loops in financial markets can create instability and lead to tipping points.